Literature DB >> 12642352

Glitazones and heart failure: critical appraisal for the clinician.

Chao-Hung Wang1, Richard D Weisel, Peter P Liu, Paul W M Fedak, Subodh Verma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642352     DOI: 10.1161/01.cir.0000054675.30348.9a

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  14 in total

Review 1.  Heart failure induced by non-cardiac drugs.

Authors:  Lars Slørdal; Olav Spigset
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Emerging treatments for post-transplantation diabetes mellitus.

Authors:  Trond Jenssen; Anders Hartmann
Journal:  Nat Rev Nephrol       Date:  2015-04-28       Impact factor: 28.314

Review 3.  Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.

Authors:  Cecilia C Low Wang; Connie N Hess; William R Hiatt; Allison B Goldfine
Journal:  Circulation       Date:  2016-06-14       Impact factor: 29.690

Review 4.  Combined thiazolidinedione-insulin therapy: should we be concerned about safety?

Authors:  André J Scheen
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  LSTM Model for Prediction of Heart Failure in Big Data.

Authors:  G Maragatham; Shobana Devi
Journal:  J Med Syst       Date:  2019-03-19       Impact factor: 4.460

6.  Thiazolidinediones: a 2010 perspective.

Authors:  Ashok Krishnaswami; Shalini Ravi-Kumar; John M Lewis
Journal:  Perm J       Date:  2010

7.  Therapeutic Implications of PPARgamma in Cardiovascular Diseases.

Authors:  Hiroshi Hasegawa; Hiroyuki Takano; Issei Komuro
Journal:  PPAR Res       Date:  2010-08-12       Impact factor: 4.964

8.  Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment.

Authors:  Koichi Node; Teruo Inoue; Valentin Boyko; Ilan Goldberg; Enrique Z Fisman; Yehuda Adler; Ehud Schwammenthal; Zipora Matas; Solomon Behar; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2009-01-28       Impact factor: 9.951

9.  Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model--the Zucker diabetic rat.

Authors:  Fabien Forcheron; Alexandra Basset; Pauline Abdallah; Peggy Del Carmine; Nicolas Gadot; Michel Beylot
Journal:  Cardiovasc Diabetol       Date:  2009-03-24       Impact factor: 9.951

10.  Potential therapeutic competition in community-living older adults in the U.S.: use of medications that may adversely affect a coexisting condition.

Authors:  Songprod Jonathan Lorgunpai; Marianthe Grammas; David S H Lee; Gail McAvay; Peter Charpentier; Mary E Tinetti
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.